This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....